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Unraveling local tissue changes 
within severely injured skeletal 
muscles in response to MSC-based 
intervention using MALDI Imaging 
mass spectrometry
Oliver Klein1, Kristin Strohschein1,2, Grit Nebrich2, Michael Fuchs2, Herbert Thiele4, 
Patrick Giavalisco3, Georg N. Duda1,2, Tobias Winkler1,2, Jan Hendrik Kobarg5, Dennis Trede5 & 
Sven Geissler  1,2
Pre-clinical and clinical studies are now beginning to demonstrate the high potential of cell therapies 
in enhancing muscle regeneration. We previously demonstrated functional benefit after the 
transplantation of autologous bone marrow mesenchymal stromal cells (MSC-TX) into a severe muscle 
crush trauma model. Despite our increasing understanding of the molecular and cellular mechanisms 
underlying MSC’s regenerative function, little is known about the local molecular alterations and their 
spatial distribution within the tissue after MSC-TX. Here, we used MALDI imaging mass spectrometry 
(MALDI-IMS) in combination with multivariate statistical strategies to uncover previously unknown 
peptide alterations within severely injured skeletal muscles. Our analysis revealed that very early 
molecular alterations in response to MSC-TX occur largely in the region adjacent to the trauma and only 
to a small extent in the actual trauma region. Using “bottom up” mass spectrometry, we subsequently 
identified the proteins corresponding to the differentially expressed peptide intensity distributions 
in the specific muscle regions and used immunohistochemistry to validate our results. These findings 
extend our current understanding about the early molecular processes of muscle healing and highlights 
the critical role of trauma adjacent tissue during the early therapeutic response upon treatment with 
MSC.
Skeletal muscles have a significant regenerative potential. However, these endogenous processes are often insuffi-
cient to recover from severe injuries, leading to fatty degeneration and scar formation, which compromise muscle 
function and its structural integrity1. Severe skeletal muscle injuries are frequently encountered in orthopedics 
and traumatology2.
Novel therapeutic strategies that aim to enhance skeletal muscle regeneration involve the local delivery of 
biologics such as growth factors and cells3. Mesenchymal stromal cells (MSCs) are promising cell source for 
such applications due to their immunomodulatory, paracrine, and differentiation potential4. Their regenerative 
capability has already been validated in several animal models of muscular dystrophy, myocardial infarction, and 
skeletal muscle trauma. We previously reported a clinically relevant muscle injury model that consists of multiple 
severe crush trauma to the soleus muscles of Sprague Dawley rats. In this model, the untreated controls consist-
ently exhibit a permanent loss in muscle function of approximately 50% compared to the uninjured contralat-
eral tissue5. However, the injection of MSCs immediately after the trauma significantly improves the functional 
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healing outcome in as early as 28 days6,7. Using placental-derived MSCs, we recently obtained similar promising 
results in a human phase I/II clinical study (phase I/II)8.
Although evidently successful, the mechanisms underlying the regenerative function of MSC are still unclear. 
Transplanted MSCs are mainly active within the early phase of muscle repair9. They seem to promote muscle 
regeneration not because of their differentiation into muscle cells or fusion with existing myofibers, but appar-
ently via paracrine effects5. Successful healing is accomplished by the spatiotemporal interplay between various 
cell types and biological processes, which is mirrored by large changes in the protein repertoire of injured mus-
cle10. Thus, the characterization of the muscle proteome after injury and how it is altered after cell therapy could 
elucidate mechanisms by which MScs induce muscle regeneration and may also enable the discovery of new 
therapeutic targets for directed interventions. This is challenging because such an endeavor requires the spatial 
assessment of local molecular alterations within the injured muscle.
Commonly used techniques to investigate tissue proteomes include liquid based proteomic approaches, e. g. 
2D gel electrophoresis or liquid chromatography (LC) based mass spectrometry11,12. However, these techniques 
do not enable a direct correlation between differentially expressed protein profiles and the tissue histology. Since, 
previous investigations have suggested that the regenerative changes are spatially restricted and dependent on 
pathophysiological surroundings, liquid based approaches might be suboptimal to gain insights into MSC’s mode 
of action13. Matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) enables the 
spatially resolved tissue assessment via specific molecular signatures (e.g. proteins, peptides, lipids, and molecules 
of cell metabolites) and allows their correlation with alterations in the tissue histology14–18. Recently, we showed 
that MALDI-IMS enables the discrimination and classification of pathophysiological muscle regions through the 
direct (in-situ) analysis of tissue sections13. Thereby, the primary traumatized muscle region can be distinguished 
from trauma adjacent tissue via the lower intensity distribution of the muscle proteins carbonic anhydrase III 
(Ca3) and skeletal muscle alpha actin (Acts).
In the current study, we used the MALDI-IMS workflow to determine spatial peptide alterations in response 
to MSC-TX. We use m/z values from Acts (as described earlier13) to discriminate between the primary trauma-
tized (tm) and trauma adjacent (tam) muscle areas, allowing us to assign peptide distributions to these specific 
pathophysiological regions. Next, we used multivariate classification methods, such as segmentation mapping, 
principle component analysis (PCA) and probabilistic latent semantic analysis (PLSA), to identify differential 
peptide distributions between the tm and tam areas of injured skeletal muscles from the MSC-TX and control 
groups. This analysis revealed that MSC-TX predominantly affects the tam region, whereas its influence on the 
tm regions is minimal. Subsequently, we use LC mass spectrometry and immunohistochemistry to identify the 
proteins corresponding to uncover peptide intensity distributions and to validate our findings in the specific 
muscle regions.
Results
MALDI IMS. We analyzed muscle specimens at day seven after injury to investigate early effects of MSC-TX. 
Mass spectra of MSC-TX and control muscles were extracted and statistical data analysis was performed by SCiLS 
Lab software. In total, we extracted 534 aligned m/z values in the typical mass range for tryptic peptides between 
m/z 800 to 3.500 (Supplementary Table 1). Average spectra of tam and tm regions of MSC-TX and control muscle 
tissues are shown exemplarily in Supplementary Fig. 1.
Determination of pathophysiological regions. According to our previous study13, we initially deter-
mined the pathophysiological regions, trauma adjacent (tam) and direct trauma (tm), within the muscles from 
both treatment groups by using the m/z values from 976 Da and 1198. We noted that the intensity distributions 
of m/z value 976 Da and 1198, significantly vary between the tam and tm region in muscles from the MSC-TX 
and control group (Table 1, Fig. 1b; AUC <0.35; p < 0.001; m/z correlation value > 0.65).The unsupervised data 
analysis of the peptide signatures by the segmentation mapping approach also results in two discriminative 
segments according to the m/z values in the soleus muscle of control and MSC-TX group (tam, blue, and tm 
region red, Fig. 1c).In total, determined regions includes 9864 (tam-MSC-TX), 9236 (tam-w/o MSC-TX), 10041 
(tm-MSC-TX) and 6809 (tm-w/o MSC-TX) spectra.
Determination of differences within the pathophysiological regions between MSC-TX and 
control muscle tissue by multivariate statistical data analysis strategies. The determination of 
differences between the tam or the tm region of MSC-TX treated and corresponding control muscles requires 
an unbiased analysis of spatial changes. The hierarchical expansion of the segmentation map, calculated by the 
bisecting k-means clustering method, results in a third segment exclusively describing the tam region of MSC-TX 
treated muscles (green, Fig. 1d). All biological replicates are shown in Supplementary Fig. 2.
Subsequently, we performed a Principal Component Analysis (PCA) to determine the largest difference in 
both pathophysiological regions between MSC-TX and control group (Fig. 1e) The principal component 1 (PC-
1) mainly captured the differences within the tam region between MSC-TX treated and control muscles (PC-1 
IMS m/z 
observed










976.44 975.43 975.43 0.0037 3.79 0.086 <0.001
1198.63 1197.62 1197.07 0.0653 54.52 0.153 <0.001
Table 1. Discrimination between primary trauma and trauma adjacent region in muscle tissue with and w/o 
MSC-TX by m/z values of ACTS.
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33.9%). PC-2 clearly discriminated tm and tam of the MSC-TX group from the corresponding regions of control 
muscles (PC-2 19.27%). All biological replicates are shown in Supplementary Fig. 3. Additionally, we performed 
a probabilistic latent semantic analysis (PLSA), which allowed the direct interpretation of score images and load-
ings. The spectra from the tam region of control muscles were characterized by high values for component 1, 
whereas the component 2 shows high values in the tam region of the MSC-TX muscles. Component 1 and 2 show 
low values in the tm region of both control and MSC-TX group (Fig. 1f). All biological replicates are shown in 
Supplementary Fig. 4. In summary, applying different unsupervised multivariate classification methods, we could 
discriminate between tam and tm region of the muscles and more importantly identified distinct differences in 
the tam region between the MSC-TX treated and control muscles. Consequently, even the individual comparison 
between the corresponding pathological regions of both treatment groups revealed that both approaches only 
very weakly discriminates between tm-CTRL vs tm-MSC-TX region, while they very well separate the tam-CTRL 
from the tam-MSC-TX area (Supplementary Fig. 5).
Determination of characteristic m/z values of MSC-TX muscle tissue. To determine characteristic 
m/z values between the unsupervised determined regions of both groups, we performed direct (region-specific) 
comparison of all 534 aligned m/z values using ROC analysis and hypothesis tests (Supplementary Table 1). A 
visualization of selected m/z-values correlating to a specific pathophysiological region is shown in Fig. 2. In total, 
Figure 1. Discrimination pathophysiological region within injured skeletal muscles of MSC-TX and control 
group. (a) H&E staining of traumatized soleus muscles from the MSC-TX (left) and control group (right). 
Primary trauma region are indicated as tm and the trauma adjacent area as tam. (b) Discrimination of tam 
and tm region by alpha skeletal muscle actin (Acts). The m/z value 976 shows significantly lower intensities 
(p < 0.05) in the tm regions compared to the tam regions of both group. (c) Spatial segmentation analysis 
with two segments results in a clear discrimination of tam tissue area (blue region) from the tm (red). (d). A 
third segment (green region) could be determined exclusively in the tam region of MSC-TX muscle tissue. 
(e) Intensity distribution of the first principal component PC1 for the considered tissue sections, which 
clearly discriminates MSC-TX muscles from corresponding regions of the control. Principal component PC2 
clearly discriminates between tm and tam region in both groups. (f). Probabilistic latent semantic analysis 
discriminates tam region of MSC-TX from the corresponding region of the control muscles. First component 
C1 shows a higher intensity in tam region of control muscles. In contrast, the second component C2 shows an 
increased intensity exclusive in the tam region of MSC-TX muscles.
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we found 45 m/z-values that discriminate the tm region of MSC-TX treated muscles from the corresponding 
region of the control muscles (AUC <0.35 or >0.65; p < 0.01; peak intensity ratio >1.2 and <0.8, Supplementary 
Table 2). For instance, we found a decreased spatial ion distribution with m/z value 1323 Da in the tm region of 
MSC-TX group compared to the corresponding region of the control group. We identified 96 m/z values which 
distinguish the tam region of MSC-TX treated muscles from the corresponding region of control muscles (AUC 
<0.35 or >0.65; p < 0.01; peak intensity ratio >1.2 and <0.8; Supplementary Table 3). In particular, the spatial 
ion distributions of the peptide-values 1489 Da, 1740Da and 1782 Da are significantly higher in the tam region of 
MSC-TX group compared to the control group. Conversely, we identified a higher intensity of m/z value 1172 Da 
in the tam region of control muscles compared MSC-TX treated muscles. Since the number of spectra in the tm 
region apparently differs between both groups (MSC-TX: 10041 and control: 6809) and thereby compromise the 
discrimination potential of the method, we performed ROC analysis also with 6000 randomly selected spectra 
from the tm region of each group. The obtained results are nearly identical to the data obtained above and provide 
evidence for the robustness of the approach (Supplementary Table 5).
Identification and validation of proteins affected by MSC-TX. To identify the proteins correspond-
ing to the detected discriminative m/z values, adjacent tissue sections were analyzed with a “bottom up” LC-MS/
MS approach (Supplementary Table 4). This analysis assigned 64 out of 141 m/z values (AUC <0.35 or >0.65; 
p < 0.01; peak intensity ratio >1.2 and <0.8) from the MALDI IMS experiment to 52 proteins (Supplementary 
Tables 2, 3). More than one identified m/z value of Col6a1 (Collagen alpha-1(VI) chain), Myl3 (myosin light 
chain 3), Hspa8 (Heat shock cognate 71 kDa) (hsp8) Tnc (tenascin-C), and Flnc (filamin C) was assigned to the 
observed m/z values from the MALDI-IMS experiment and assumed as correctly identified according to the IMS 
guidelines (Table 2)19.
The m/z values of Col6a1 showed a decrease in the density distribution in the tm as well as tam region of 
MSC-TX compared to the control muscle. Ion intensity of m/z values corresponding to Ca3, are significantly 
higher (AUC <0.35; p < 0.01; peak intensity ratio >1.2 and <0.8) in tam region of control compared to the tam 
region of MSC-TX muscle tissue, but only minor differences between the tm region of both groups. Furthermore, 
we found that ion intensity of m/z values of Hspa8 significantly increased in the tam as well as in tm region 
of MSC-TX treated muscles compared to the control (AUC <0.35; p < 0.01; peak intensity ratio >1.2 and 
<0.8). M/z values of TNC, FlnC and Myl3 were significantly higher in tam region of MSC-TX in comparison to 
tam-control muscle tissue.
The assignments based on LC-MS/MS-identified peptide lists have to be verified by immunohistological stain-
ing (IHC) of the respective tissue20. Exemplarily, tenascin-C and carbonic anhydrase III were validated by immu-
nohistochemistry. We observed a clear positive staining of tenacin-C in the tam region of the MSC-TX group 
compared to the same region of the control group. Similarly, IHC staining against carbonic anhydrase III revealed 
a positive staining in the tam region of control muscles compared to the corresponding region of MSC-TX treated 
muscles (Fig. 3). These results confirm the observations based on IMS experiments, which determine increased 
Figure 2. Spatial distribution of characteristic m/z values for the traumatized and trauma adjacent regions of 
MSC-TX and control muscle tissue. The m/z-values 1489, 1740 and 1782 are significant increased (p < 0.05) in 
tam region of MSC-TX treated muscles in comparison to the control samples. In contrast, intensity distribution 
of m/z-values 1323 is significantly increased (p < 0.05) in tm-region and m/z-values 1172 is increased in the 
tam-region of control muscles.
www.nature.com/scientificreports/





























1323.71 1322.70 0.63 0.70 0.178 0.252 1.322.70 0.003 2.2 40 DRLLPPTQNNR
Col6a Collagen VI alpha 1
1701.98 1700.97 0.54 0.59 0.192 0.216 1.700.86 0.112 65.6 93 VAVVQYSGQGQQQPGR
979.58 978.57 0.81 0.45 0.361 0.172 978.49 0.079 80.5 33 LMQVEFGR
1328.64 1327.63 0.54 0.67 0.333 0.232 1.327.71 0.074 55.4 34 SGDDVRGPSVVLK




71 kDa1487.82 1486.81 2.4 1.28 0.815 0.672 1.486.69 0.116 77.8 63 TTPSYVAFTDTER
1172.57 1171.57 0.44 0.73 0.097 0.251 1.171.64 0.077 65.4 35 GGPLSGPYRLR
Ca3 Carbonic anhydrase 31390.75 1389.74 0.51 0.79 0.111 0.310 1.389.72 0.023 16.7 40 SMLRGGPLSGPYR
1396.76 1395.76 1.56 0.819 0.708 0.335 1.395.75 0.011 7.5 73 ALGQNPTQAEVLR
Myl3 Myosin light chain 31782.99 1781.98 1.37 1.1 0.688 0.538 1.781.94 0.040 22.6 101 AAPAPAAAPAAAPEPERPK
937.56 936.55 2.0 1.42 0.712 0.595 936.50 0.048 51.4 42 LGSFGSITR
Flnc Filamin C
1489.90 1488.89 1.56 1.28 0.728 0.620 1.488.77 0.116 78.2 31 GVAGVPAEFSIWTR
1668.81 1667.80 4.14 1.44 0.977 0.696 1.667.81 0.013 60.4 32 YAPISGGDHAEIDVPK
Tnc Tenascin-C
1.740.95 1.739.94 2.0 1.61 0.852 0.738 1.739.83 0.105 60.4 32 EGDPATINAATEIDAPR
Table 2. MALDI imaging derived identified proteins which different intensity distribution between muscle 
with and w/o MSC-TX.
Figure 3. Immunohistochemical validation of tenascin-C and carbonic anhydrase 3. Shown are MALDI IMS 
spectra displaying the identified average m/z species of (a) tenascin-C (TnC) and (b) carbonic anhydrase 3 
(Ca3) within the tam and tm region of MSC-TX and control muscles, respectively. Immunohistochemical 
staining revealed a stronger expression of TnC (above right subplot) in tam region of MSC-TX muscle, whereas 
the expression of Ca3 is elevated in the tam region of control muscles.
www.nature.com/scientificreports/
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intensity distributions of peptide values from carbonic anhydrase III in the tam region of control muscle tissue 
and from tenacin-C in the tam region of MSC-TX muscle tissue (Fig. 3). As an example, the ion distributions of 
m/z values 1740Da, 1168 Da (Tnc) and m/z values 1390 Da, 1172 Da (Ca3) for all biological replicates are shown 
in Supplementary Fig. 6.
Discussion
An ever-increasing number of reports suggest that the transplantation of MSCs from different sources improves 
the regeneration in a wide range of disease related to muscle tissue, including muscular dystrophy, cardiomyo-
pathy, and severely injured skeletal muscles7,21–23. In a clinically relevant injury model, we recently showed that 
MSC-TX improves the functional healing outcome (28 and 56 days after injury) by remodeling scar tissue and 
promoting the formation of new myofibers5. However, the underlying mechanism by which MSCs promote 
muscle repair remains largely unknown. Recent studies provide evidence that MSC administration improves 
muscle regeneration, not because of differentiation into muscle fibers, but apparently due to their paracrine and 
immunomodulatory effects mediated by the secretion of various cytokines and other growth factors24,25. Using 
doxorubicin-induced cardiomyopathy mice model, Zhang et al. provided elegant insight into the paracrine 
effects by which MSCs improve the structural and functional healing outcome, and highlighted the critical role 
of Rap1-mediated NF-κB signaling and the secretion of MIF and GDF-15 in this process26,27. It is important to 
note that the regenerative properties of MSCs are very highly dependent on their microenvironment25,28. For 
example, Ren et al. showed that MSCs have no constitutive immunomodulatory function, but become potently 
immunosuppressive in conjunction with a pro-inflammatory (injury) environment29. It has also been shown that 
the paracrine effects of MSCs depend on cell-cell interactions and especially structural characteristics of their sur-
rounding matrix30. Apart from an incomplete understanding of the precise mechanism by which MSCs promote 
tissue restoration, there is a paucity of data about early molecular changes within the injured muscle in response 
to the MSC-based intervention. Since previous studies provide the evidence that MSCs survive at most only the 
first seven days after their injection into the muscle, their direct regenerative effect seems to be limited to the ini-
tial phase of the healing process9. Surprisingly, we found no (immune) histological difference between treated and 
untreated muscles seven days after injury in an earlier investigation5. This may be in part due to the limitation of 
these standard techniques to describe very early structural and molecular alterations within the muscle.
MADLI IMS analysis allowed us to determine in situ the spatial intensity distribution of peptide and proteins 
signatures in skeletal muscle tissue. This methodology provides several advantages in contrast to other supervised 
imaging methods like IHC or in situ hybridization, such as the high specificity of MS detection, picayune sample 
preparation, wide range of analytes and multiplex capability. Thus, IMS facilitates the acquisition of molecular 
signatures while preserving their location in the tissue. As disadvantage is that, the technique only allows the 
determination of abundant proteins and peptides due of the absence of a peptide separation procedure. However, 
thousands of spectra were acquire in an automatic manner and evaluated by unsupervised multivariate statistical 
methods. This enables the determination of novel region-specific alterations in response to MSC-TX, which have 
so far remained hidden from conventional histological methods.
In this work, we analyzed six different muscle tissue sections with the objective of determining local pep-
tide signatures (sub-regions) within the pathophysiological areas, which differ between the muscles of MSC-TX 
treated and untreated control animals. Since the traditional H&E staining only approximately distinguishes these 
regions, we used previously published m/z values of alpha skeletal muscle actin to determine primary trauma 
(tm) and trauma adjacent (tam) regions in injured skeletal muscle tissue13. The discrimination of these patho-
physiological regions was ensured by an unbiased segmentation approach based on bisecting k-means clustering. 
This approach results in two clusters, distinguishing this region similar to the Acts m/z values.
The analysis of data sets obtained by IMS experiments represents a challenge when different treatments, repli-
cates and development phases are to be compared and molecular features to be extracted. Segmentation mapping, 
PCA and PLSA were used in this study as multivariate statistical models for the analysis of a diverse set of MALDI 
IMS data. The algorithms are designed to categorize the data set according to mass spectral characteristics. The 
classification of pathophysiological regions by characteristic peptide makers is based on the identification of 
common signal patterns represented in particular areas (tissues) of the sample sections. The k-means clustering 
is thought to be well suited to get a first impression about the diversity within the sample set. This information 
can be used to further apply the PLSA algorithm, for which a prior knowledge about the diversity of the sample 
material is recommended. The results obtained by PLSA are more specific in displaying molecular features of the 
tissues than those observed by segmentation mapping based on k-means clustering method.
Consistently, grouping spectra according to spectral similarities (segmentation approach), determination of 
the largest variance compound (PCA) and calculation of spatial tissue components (PLSA), suggest that MSC-TX 
predominantly leads to molecular alteration in the tam region of skeletal muscle. The fact that distinct evaluation 
strategies using different algorithms reveal similar results underscores the robustness of the observation.
These results show that the MALDI-IMS technique in combination with unsupervised data evaluation strate-
gies allows a promising unbiased classification of different regions in injured skeletal muscle. It enables the deter-
mination of molecular changes after MSC-TX, which cannot be observed by conventional supervised techniques 
such as IHC.
Following this evaluation, differential m/z values were identified between pathophysiological regions (tam and 
tm) of control and MSC-TX groups. A large number of isobaric ions31 and the presence of so-called chimera spec-
tra32 adversely affected the identification of m/z values by MS/MS on tissues. Therefore, we used a corresponding 
“bottom-up” LC-MS/MS analysis, which enabled the identification of the obtained MALDI-IMS m/z value33. 
The intensity distribution of these m/z values changes depends on pathophysiological environments of MSC-TX 
in comparison to the control muscle tissue. Since ion suppression, efficient extraction and sample complexity 
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negatively influence the ionization of peptides, the combination of MALDI-IMS and LC−MS/MS requires more 
than one peptide to correctly identify the corresponding proteins34.
In particular, Ca3, Myl3, TnC, Flnc, Col6a and Hspa8 were reliably identified and indicate the differences in 
the tam and tm regions between MSC-TX and control muscle tissues. Other differentially expressed m/z species 
(Supplementary Tables 1–3) remain unidentified so far or were identified with less than two peptides and require 
further investigation.
As mentioned above, although the benefits of MSC-TX to form and function of the injured muscles are 
acknowledged, little is still known about mechanistic effects of MSC-TX on the pathophysiological environ-
ments in injured skeletal muscle. The identification of differentially regulated proteins allow new insights into the 
molecular alterations in the muscle tissue in response to MSC-TX. For example, the high intensity distribution 
of TnC and low intensity distribution of Ca3 m/z species in trauma adjacent regions of injured skeletal mus-
cle after MSC-TX was previously unknown, and could be verified by immunohistological staining. Tenascin-C 
is present during the wound healing, morphogenesis, and as a component of the stem cell niche35,36. It is also 
expressed after mechanical stress in actively remodeling musculoskeletal tissue and protects naturally occurring 
MSC from FasL-induced apoptosis37,38. Furthermore, TnC is described as an autonomously secreted factor, which 
supports fetal muscle stem cells regenerative capacity39. Thus, results of the present study suggest, that the process 
of remodeling and morphogenesis is more advanced in the MSC-TX treated muscles in comparison to the control 
muscles.
This suggestion is in line with a decrease in the intensity distribution of Ca3 in the tam region of MSC-TX 
muscle tissue. Ca3 is a muscle-specific, cytosolic protein of slow twitch oxidative fibers (type I muscle fibers) and 
catalyzes the reversible hydration of carbon dioxide and thus is involved in buffer systems and ion fluxes in cells40. 
The native soleus has predominantly slow muscle fiber muscle phenotype muscle, and our previous investigations 
suggest that successful regeneration is depending on the fast restoration original muscle phenotype3,5.
Additionally, we identified Collagen VI alpha 1 (Col6a), Heat shock cognate 71 kDa (Hspa8), and Filamin C 
(FlnC) as potential biological factors involved in therapeutic muscle response. Col6a shows a decrease in intensity 
in the tm region of the MSC-TX in comparison to the control injured skeletal muscle. This protein is an extracel-
lular matrix protein and regulates satellite cell self-renewal and muscle regeneration. A lack of Col6a1 results in a 
reduced self-renewal capability after injury41. Peptide intensity distribution of Hspa8 were higher in the primary 
trauma and the trauma adjacent region of the injured skeletal muscle treated with MSC-TX. The expression of 
heat shock protein members highly depends on the cell microenvironment and these proteins are involved in the 
survival, prevention of apoptosis and the defense against extracellular induced stresses of different (mesenchy-
mal) cell types28. The corresponding peptide values of FlnC were higher in the tam region of MSC-TX treated 
muscles and this protein interacts with actin and various proteins in the sarcoglycan complex. It is involved in 
actin polymerization, mechanoprotection, signal transduction and cellular migration, as well as the regulation of 
the contractile apparatus42–45. Furthermore, filamin C participates in the signal transduction of cellular migration 
of the myogenic progenitor cell population, which is mandatory for muscle development46. Myl3 is an alkali slow 
Myosin light chain isoform (Mlc1sb) which is expressed in slow muscle and plays a role in molecular motor of 
muscle contraction47. Therefore, the increase of m/z values in tam region of MSC-TX muscle may indicate an 
advanced regeneration process in this region compared to the control group. Presently, these potential candidates 
have not been evaluated by IHC and require further elucidation efforts.
In summary, we show that MALDI-IMS is a suitable technique to identify proteomic signatures and allows 
distinguishing changes of molecular architecture in pathophysiological regions (trauma and trauma adjacent) due 
to MSC-TX in injured muscle tissue. Furthermore, the results of complementary unsupervised multivariate clas-
sification methods (PLSA, PCA, segmentation map) suggest that MSC-TX induces greater changes in the trauma 
adjacent tissue region. The uniqueness of our approach is the representation and quantification of the entire skel-
etal muscle and this beyond the primary traumatized region. To the best of our knowledge, there are no compara-
ble studies, which include the trauma-adjacent regions and investigate early molecular alterations in response to a 
cell-based intervention. Most other studies primarily focusing on the actual injury region at very late time points 
or on the transplanted cells themselves. Our research shows that the very early molecular alterations occur largely 
in the region adjacent to the trauma and only to a small extent in the actual trauma region. These data contribute 
to our current understanding of the early stages of muscle healing and support the identification of new targets 
for direct (e.g. pharmacological) intervention.
Materials and Methods
Study design. Our main objective was to assess local changes of peptide distribution within injured skel-
etal muscles in response to the MSC-TX treatment by using the MALDI-IMS technique. Muscle sections were 
obtained from an unrelated study using our established clinically relevant injury model that consists of multiple 
severe crush trauma in the soleus muscle of female Sprague Dawley rats. The animal experiments were approved 
by local legal representative (Landesamt für Gesundheit und Soziales, Berlin: Registration number: G0119/12). 
In this model, animals exhibited a permanent loss of muscle force approximately 40–50%, which was signifi-
cantly improved by the transplantation of autologous MSCs (Supplementary Fig. 7). To investigate early molecu-
lar changes in response to the intervention, we used tissue samples obtained seven days after trauma from n = 3 
with MSC-TX and n = 3 corresponding controls. The muscle sections were analyzed by MALDI-IMS as described 
below. In order to match the obtained m/z values with the corresponding proteins, we used a “bottom-up”-nano 
LC - MS/MS approach on the adjacent tissue sections from control groups. Identified proteins were subsequently 
validated by immunohistochemical staining of whole muscle sections.
Animal experiments. Biological samples were obtained during a previous study (Registration number: 
G0119/12) and carried out in compliance with the policies and principles established by the Animal Welfare 
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Act, the NIH Guide for Care and Use of Laboratory Animals, and the national animal welfare guidelines. Briefly, 
female Sprague Dawley rat were used (4 month old, weighing 200–250 g, Charles River, Sulzbach, Germany). 
Bone marrow aspiration, MSC isolation, MSC phenotype and differentiation, and animal surgeries were per-
formed as previously described5,48. Bone marrow aspiration was conducted on both tibiae of all animals and 
MSCs were isolated by the plastic adherence method and cultured under normal conditions. Three weeks later, a 
standardized crush injury was performed on the left soleus muscle (unilateral surgery) as described earlier6. For 
this purpose, the soleus muscle was mobilized and crushed bluntly through a 3 cm posterolateral longitudinal 
incision of the skin and underlying fascia from the lateral gastrocnemius head to the achilles tendon. A curved 
artery clamp with tips surrounded by polyethylene tubes was used to avoid lesions of the muscle fascia. The 
muscle was manually clamped for 20 seconds. Standardized pressure on the muscle was ensured by closing the 
forceps to its third stage, resulting in a closing pressure of 112 ± 5.1 N48. After thorough rinsing with saline solu-
tion, the superficial muscles and the skin were sutured. One hour after trauma, 2.5 × 106 MSCs were washed and 
suspended in 50 µl of a 0.9% saline solution and locally injected into the soleus muscle using a 25-gauge cannula. 
The control group received an injection of 0.9% saline solution in the same manner. At day 7 after injury, animals 
were sacrificed and the muscles were harvested for subsequent analysis.
Tissue Preparation and MALDI-IMS data acquisition. Tissue preparation and MALDI-IMS data 
acquisition were performed as previously described13. Briefly, paraformaldehyde (PFA)-fixed specimens were 
dehydrated by washing sequentially with increasing concentrations of ethanol, subsequently cleared in xylene, 
and embedded in paraffin. Formalin-fixed, paraffin-embedded sections (FFPE,10 µm) were prepared from par-
affin blocks on a microtome (Leica RM 2125). In total six tissue sections were analyzed by MALDI Imaging 
(three MSC-TX and three control animals). Two muscle tissue sections, one from MSC-TX and one from control 
group, respectively, were transferred on the same Indium-Tin-Oxide slides (Bruker Daltonik, Bremen, Germany). 
Sections were dewaxed and passed through decreasing concentrations of ethanol according to an adapted protocol 
from Casadonte R et al.ii49. Using an automated spraying device (ImagePrep; Bruker Daltonik, nine spray cycle), 
200 µl trypsin solution (20 µg, 20 mM ammonium bicarbonate/acetonitrile 9:1) was applied onto the section. After 
tissue incubation (3 h at 37 °C; moist chamber), matrix solution (1 ml [7 g/L] a-cyano-4-hydroxycinnamic acid 
in 50% acetonitrile and 1% trifluoroacetic acid) was applied using ImagePrep (15% power ± 40% modulation, 
60 spray cycle). MALDI-IMS data acquisition was performed in positive ion reflector mode on an Autoflex III 
MALDI-TOF/TOF using flexControl 3.0 and flexImaging 3.0 software (Bruker Daltonik). Measurement settings 
were as follows: detection range of m/z 800–3500, 200 laser shots per spot, sampling rate of 0.5 GS/s, and ras-
ter width = 80 µm. External calibration was performed using a peptide calibration standard (Bruker Daltonik), 
which was separately spotted close to the tissue section area. Spectra processing was performed in flexAnalysis 
3.0 (Bruker Daltonik) with spectra smoothing and baseline subtraction. After MALDI-IMS experiments, the 
matrix was removed with 70% ethanol and the tissue sections were stained with hematoxylin and eosin (HE) as 
histological overview staining49.
Statistical data analysis. Statistical data analysis was perform using SCiLS Lab software (Version2015b, 
SCiLS GmbH, Bremen, Germany). MALDI-IMS raw data was imported into the SCiLS Lab software and con-
verted to the SCiLS Lab file format. Simultaneous preprocessing of all data sets was perform to ensure better 
comparability between the sample sets. Imported data were pre-processed by convolution baseline removal 
(width: 20) and total ion count (TIC) normalization. Peak finding and alignment were created using a standard 
pipeline with the following settings: ± 0.156 Da interval width, mean interval processing, medium smoothing 
strength50–52. The primary trauma (tm) and the trauma adjacent tissue (tam) area of both groups were defined 
as regions of interest (ROI) and annotated by using the m/z value 976 Da, a previously published discrimination 
marker (identified as alpha skeletal muscle actin [Acts])13. To confirm the annotation another m/z value for Acts 
(m/z 1198) was used (AUC <0.35; p < 0.001; m/z correlation value >0.65).
In order to assess the spectral diversity among the sample sets, different multivariate clustering algorithms 
were applied. Based on the peptide signatures, data mining was perform by using a standard segmentation pipe-
line as published previously13,50,51. Peaks were selected using the Orthogonal Matching Pursuit (OMP) algorithm52 
and top down segmentation were performed by bisecting k-means clustering, which performs a top-to-bottom 
splitting of mass spectra according to their similarities. Common spatial identities of molecular patterns in the 
sample were subsequently visualized by colour coding the resulting segmentation map.
To define common molecular features among the sample sets different unsupervised multivariate classifi-
cation methods for mass spectra representing the tm and tam area of MSC-TX and control tissue were applied: 
Probabilistic Latent Semantic Analysis (PLSA) and principal component analysis (PCA) were performed as pre-
viously described53,54.
Theoretically, four principal components can be assumed: (i) tm of MSC-TX group, (ii) tm of control group, 
(iii) tam of MSC-TX group, and (iv) tam of control group. To ensure that no further sub-structures (matrix cluster 
and noise spectra) were included into the ROI, PLSA and PCA were performed with five components and the 
following settings: (i) Interval width of ± 0.156 Da, and (iii) individual spectra. In particular, PLSA was performed 
with deterministic initialization and PCA with unit variant scaling.
Receiver operating characteristic analysis (ROC) was used to assess the quality of all m/z values within specific 
ROIs to discriminate between MSC-TX and control muscles. For this method, the number of spectra in the ROIs 
of both groups should be approximately the same. If that was not the case, 6000 randomly select spectra per ROI/
group were used. To determine statistical significance, discriminating m/z values (peaks) with a AUC <0.35 or 
>0.65 were subsequently analyzed using Wilcoxon rank sum test. M/Z values with a delta peak intensity of >0.3 
and P < 0.001 were assumed as potential markers.
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Identification of m/z values by “bottom-up”-nUPLC mass spectrometry. To identify m/z values, 
complementary protein identification was performed on adjacent muscle sections by a “bottom-up”-nano LC 
- MS/MS approach as published previously13. Briefly, tissue digestion (20 µg trypsin, 20 mM ammonium bicar-
bonate /acetonitrile 9:1) was performed via ImagePrep. Peptides for nUPLC -MS/MS analysis were extracted 
directly from adjacent tissue sections into 40 µl of 0.1% triflouroaceticacid (TFA; 15 min incubation at room 
temperature). Peptides were separated 2–60% acetonitrile/in 0.1% formic acid) using an analytical UPLC System 
(Waters, PST C18 nanoACQUITY column; flow rate 400 nl/min, 70 min) and analyzed via Orbitrap XL mass 
spectrometer (Thermo). All raw spectra from the MS/MS measurement were converted to mascot generic files 
(.mgf) using the ProteoWizard software55. Mass spectra were analyzed using Mascot search engine (version 2.4, 
MatrixScience; UK) searching the UniProt database. Search was performed with the follwing set of parame-
ters:: (i) taxonomy: Rattus norvegicus, (ii) proteolytic enzyme: trypsin, (iii) peptide tolerance: 10ppm, (iv) max-
imum of accepted missed cleavages: 1, (v) peptide charge: 2+, 3+, 4+; (vi) variable modification: oxidation 
(M); (vii) MS/MS tolerance: 0.8 Da, and (viii) MOWSE score >25. The results were exported as.csv files from 
Mascot. Identification of MALDI-IMS m/z values by using an LC-MS/MS reference list requires the accordance of 
more than one peptide (mass differences <0.9 Da) to subsequently correctly assign the corresponding protein34. 
Peptides with lowest mass difference to the LC-MS/MS reference list value were assumed as a match.
Data availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
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